<p>Silence Therapeutics plc has announced that Craig Tooman will step down as President, Chief Executive Officer, and Board member effective 14 December 2025. Iain Ross, Chairman of the Board, will serve as interim leader. James Ede Golightly has been re-appointed to the Board of Directors, and an additional US-based Board member is expected to be appointed in the future. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Silence Therapeutics plc published the original content used to generate this news brief via Business Wire (Ref. ID: 20251215323930) on December 15, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

<p>Silence Therapeutics plc announced that Craig Tooman will step down as President, CEO, and Board member on December 14, 2025. Iain Ross, Chairman of the Board, will serve as interim leader. James Ede Golightly has been re-appointed to the Board, and a new US-based Board member is expected to be appointed.</p>

Silence Therapeutics Appoints Iain Ross as Interim Leader